0000932440-05-000065.txt : 20120705
0000932440-05-000065.hdr.sgml : 20120704
20050207200154
ACCESSION NUMBER: 0000932440-05-000065
CONFORMED SUBMISSION TYPE: SC 13G
PUBLIC DOCUMENT COUNT: 3
FILED AS OF DATE: 20050208
DATE AS OF CHANGE: 20050207
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: PHARMION CORP
CENTRAL INDEX KEY: 0001203866
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FILING VALUES:
FORM TYPE: SC 13G
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-79338
FILM NUMBER: 05581876
BUSINESS ADDRESS:
STREET 1: 2525 28TH STREET
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 720 564 9100
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: PROQUEST INVESTMENTS II LP
CENTRAL INDEX KEY: 0001143544
IRS NUMBER: 223764772
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G
BUSINESS ADDRESS:
STREET 1: 600 ALEXANDER PARK
STREET 2: SUITE 204
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 6099193560
MAIL ADDRESS:
STREET 1: 600 ALEXANDER PARK
STREET 2: SUITE 204
CITY: PRINCETON
STATE: NJ
ZIP: 08540
SC 13G
1
s13g-a_990848.txt
SCHEDULE 13G
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13G
(AMENDMENT NO. 1)*
UNDER THE SECURITIES EXCHANGE ACT OF 1934
PHARMION CORPORATION
(Name of Issuer)
COMMON STOCK, $.001 PAR VALUE
(Title of Class of Securities)
71715B 40 9
(CUSIP Number)
DECEMBER 31, 2004
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
|_| Rule 13d-1(b)
|X| Rule 13d-1(c)
|_| Rule 13d-1(d)
--------------------------
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 or otherwise subject to the liabilities of that
section of the Act but shall be subject to all other provisions of the Act
(however, SEE the NOTES).
1
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
ProQuest Investments II, L.P. 22-3764772
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP** (a) |_|
(b) |X|
3. SEC USE ONLY
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
5. SOLE VOTING POWER
NUMBER OF
-0-
SHARES
6. SHARED VOTING POWER
BENEFICIALLY
688,486
OWNED BY
7. SOLE DISPOSITIVE POWER
EACH
-0-
REPORTING
8. SHARED DISPOSITIVE POWER
PERSON WITH
688,486
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
688,486
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES** |_|
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
2.17%
12. TYPE OF REPORTING PERSON**
PN
** SEE INSTRUCTIONS BEFORE FILLING OUT
2
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
ProQuest Investments II Advisors Fund, L.P. 22-3784567
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP** (a) |_|
(b) |X|
3. SEC USE ONLY
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
5. SOLE VOTING POWER
NUMBER OF
-0-
SHARES
6. SHARED VOTING POWER
BENEFICIALLY
29,212
OWNED BY
7. SOLE DISPOSITIVE POWER
EACH
-0-
REPORTING
8. SHARED DISPOSITIVE POWER
PERSON WITH
29,212
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
29,212
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES** |_|
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0.09%
12. TYPE OF REPORTING PERSON**
PN
** SEE INSTRUCTIONS BEFORE FILLING OUT
3
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
ProQuest Associates II LLC 22-3764735
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP** (a) |_|
(b) |X|
3. SEC USE ONLY
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
5. SOLE VOTING POWER
NUMBER OF
-0-
SHARES
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 717,698
EACH 7. SOLE DISPOSITIVE POWER
REPORTING -0-
PERSON WITH 8. SHARED DISPOSITIVE POWER
717,698
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
717,698
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES** |_|
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
2.27%
12. TYPE OF REPORTING PERSON**
OO
** SEE INSTRUCTIONS BEFORE FILLING OUT
4
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Jay Moorin
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP** (a) |_|
(b) |X|
3. SEC USE ONLY
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
5. SOLE VOTING POWER
NUMBER OF
-0-
SHARES
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 717,698
EACH 7. SOLE DISPOSITIVE POWER
REPORTING -0-
PERSON WITH 8. SHARED DISPOSITIVE POWER
717,698
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
748,948(1)
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES** |_|
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
2.37%
12. TYPE OF REPORTING PERSON**
IN
** SEE INSTRUCTIONS BEFORE FILLING OUT
-----------------------
(1) Amount assumes exercise by Mr. Moorin of his stock options to purchase
31,250 shares of common stock.
5
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Alain Schreiber
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP** (a) |_|
(b) |X|
3. SEC USE ONLY
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States Resident Alien
5. SOLE VOTING POWER
NUMBER OF
-0-
SHARES
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 717,698
EACH 7. SOLE DISPOSITIVE POWER
REPORTING -0-
PERSON WITH 8. SHARED DISPOSITIVE POWER
717,698
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
717,698
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES** |_|
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
2.27%
12. TYPE OF REPORTING PERSON**
IN
** SEE INSTRUCTIONS BEFORE FILLING OUT
6
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Joyce Tsang
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP** (a) |_|
(b) |X|
3. SEC USE ONLY
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
5. SOLE VOTING POWER
NUMBER OF
-0-
SHARES
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 717,698
EACH 7. SOLE DISPOSITIVE POWER
REPORTING -0-
PERSON WITH 8. SHARED DISPOSITIVE POWER
717,698
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
717,698
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES** |_|
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
2.27%
12. TYPE OF REPORTING PERSON**
IN
** SEE INSTRUCTIONS BEFORE FILLING OUT
7
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Pasquale DeAngelis
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP** (a) |_|
(b) |X|
3. SEC USE ONLY
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
5. SOLE VOTING POWER
NUMBER OF
-0-
SHARES
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 717,698
EACH 7. SOLE DISPOSITIVE POWER
REPORTING -0-
PERSON WITH 8. SHARED DISPOSITIVE POWER
717,698
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
717,698
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES** |_|
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
2.27%
12. TYPE OF REPORTING PERSON**
IN
** SEE INSTRUCTIONS BEFORE FILLING OUT
8
ITEM 1(A). NAME OF ISSUER.
Pharmion Corporation (the "Company").
ITEM 1(B). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES.
The Company's principal executive offices are located at 2525 28th Street,
Boulder, CO 80301.
ITEMS 2(A). NAME OF PERSON FILING.
This statement is filed on behalf of the following persons with respect to
shares of common stock of the Company and stock options to purchase shares of
common stock of the Company:
(i) ProQuest Investments II, L.P., a Delaware limited partnership
("Investments II"), with respect to Shares beneficially owned by it;
(ii) ProQuest Investments II Advisors Fund, L.P., a Delaware limited
partnership ("Advisors Fund"), with respect to Shares beneficially owned by it;
(iii) ProQuest Associates II LLC, a Delaware limited liability company
("Associates II"), as General Partner of Investments II and Advisors Fund, with
respect to Shares beneficially owned by Investments II and Advisors Fund;
(iv) Jay Moorin, an individual and a member of Associates II ("Moorin"),
with respect to Shares beneficially owned by Investments II and Advisors Fund;
(v) Alain Schreiber, an individual and a member of Associates II
("Schreiber"), with respect to Shares beneficially owned by Investments II and
Advisors Fund;
(vi) Joyce Tsang, an individual and a member of Associates II ("Tsang"),
with respect to Shares beneficially owned by Investments II and Advisors Fund;
and
(vii) Pasquale DeAngelis, an individual and a member of Associates II
("DeAngelis"), with respect to Shares beneficially owned by Investments II and
Advisors Fund.
The foregoing persons are hereinafter are referred to collectively as the
"Reporting Persons." Any disclosures herein with respect to persons other than
the Reporting Persons are made on information and belief after making inquiry to
the appropriate party.
ITEM 2(B). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE.
The address of the principal business office of each of the Reporting
Persons is 600 Alexander Park, Suite 204, Princeton, NJ 08540.
9
ITEM 2(C). CITIZENSHIP.
Mr. Moorin, Ms. Tsang and Mr. DeAngelis are United States citizens. Mr.
Schreiber is a United States resident alien. Investments II and Advisors Fund
are Delaware limited partnerships organized under the laws of the State of
Delaware. Associates II is a Delaware limited liability company organized under
the laws of the State of Delaware.
ITEM 2(D). TITLE OF CLASS OF SECURITIES.
Common stock, par value $0.001 per share.
ITEM 2(E). CUSIP NUMBER.
71715B 40 9
ITEM 3.
If this statement is filed pursuant to Rules 13d-1(b)or 13d- 2(b)or (c),
check whether the person filing is a:
(a) |_| Broker or dealer registered under Section 15 of the Act,
(b) |_| Bank as defined in Section 3(a)(6)of the Act,
(c) |_| Insurance Company as defined in Section 3(a)(19)of the Act,
(d) |_| Investment Company registered under Section 8 of the
Investment Company Act of 1940,
(e) |_| Investment Adviser in accordance with Rule 13d-1
(b)(1)(ii)(E),
(f) |_| Employee Benefit Plan or Endowment Fund in accordance with
13d-1 (b)(1)(ii)(F),
(g) |_| Parent Holding Company or control person in accordance with
Rule 13d-1 (b)(1)(ii)(G),
(h) |_| Savings Association as defined in Section 3(b)of the Federal
Deposit Insurance Act,
(i) |_| Church Plan that is excluded from the definition of an
investment company under Section 3(c)(14)of the Investment
Company Act of 1940,
(j) |_| Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
If this statement is filed pursuant to 13d-1(c), check this box: |X|
10
ITEM 4. OWNERSHIP.
The percentages used herein are calculated based upon 31,656,158 shares
issued and outstanding, as of November 5, 2004, based upon the Company's
Quarterly Report on Form 10-Q for the quarter ended September 30, 2004. As of
the close of business on December 31, 2004, the Reporting Persons owned shares
of the Company's common stock in the amounts and percentages listed below:
A. PROQUEST INVESTMENTS II, L.P.
(a) Amount beneficially owned: 688,486
(b) Percent of class: 2.17%
(c) (i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: 688,486
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition: 688,486
B. PROQUEST INVESTMENTS II ADVISORS FUND, L.P.
(a) Amount beneficially owned: 29,212
(b) Percent of class: 0.09%
(c) (i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: 29,212
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition: 29,212
C. PROQUEST ASSOCIATES II LLC
(a) Amount beneficially owned: 717,698
(b) Percent of class: 2.27%
(c) (i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: 717,698
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition: 717,698
11
G. JAY MOORIN
(a) Amount beneficially owned: 748,948 (assumes exercise by Mr. Moorin
of his stock options to purchase 31,250 shares of common stock)
(b) Percent of class: 2.37%
(c) (i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: 717,698407
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition: 717,698
H. ALAIN SCHREIBER
(a) Amount beneficially owned: 717,698
(b) Percent of class: 2.27%
(c) (i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: 717,698
(iii) Sole power to dispose or direct the disposition: -0-
(iv)Shared power to dispose or direct the disposition: 717,698
I. JOYCE TSANG
(a) Amount beneficially owned: 717,698
(b) Percent of class: 2.27%
(c) (i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: 717,698
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition: 717,698
J. PASQUALE DEANGELIS
(a) Amount beneficially owned: 1,435,407
(b) Percent of class: 2.27%
(c) (i) Sole power to vote or direct the vote: -0-
12
(ii) Shared power to vote or direct the vote: 717,698
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition: 717,698
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities, check the following. |X|
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
To the knowledge of the Reporting Persons, no other person has the right
to receive or the power to direct the receipt of dividends from, or the proceeds
from the sale of, a number of the Shares which represents more than five percent
of the number of outstanding shares of the Shares.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
Not Applicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
Not Applicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP.
Not Applicable.
ITEM 10. CERTIFICATIONS.
Each of the Reporting Persons hereby makes the following certification:
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were not acquired and are not held for the
purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.
13
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
DATED: February 7, 2005
/s/ Pasquale DeAngelis
---------------------------------------
Pasquale DeAngelis, individually, as a
member of ProQuest Associates II LLC,
and as a member of ProQuest Associates
II LLC on behalf of ProQuest Investments
II, L.P. and ProQuest Investments II
Advisors Fund, L.P.
*
---------------------------------------
Jay Moorin, individually
*
---------------------------------------
Alain Schreiber, individually
*
---------------------------------------
Joyce Tsang, individually
*By: /s/ Pasquale DeAngelis
--------------------------------------
Pasquale DeAngelis, Attorney-in-Fact
Power of attorney filed as an exhibit hereto
Index Exhibit
SCHEDULE 13G
EXHIBIT NUMBER EXHIBIT DESCRIPTION
-------------- -------------------
99.1 Joint Filing Agreement
99.2 Power of Attorney
14
EX-99
2
ex99-1_990863.txt
EXHIBIT 99 - JOINT FILING AGREEMENT
Exhibit 99.1
JOINT FILING AGREEMENT
The undersigned hereby agree that the statement on Schedule 13G with
respect to the shares of common stock of Pharmion Corporation is, and any
amendment thereto signed by each of the undersigned shall be, filed on behalf of
each of the undersigned pursuant to and in accordance with the provisions of
Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended.
The undersigned hereby further agree that this Joint Filing Agreement be
included as an exhibit to such statement and any such amendment. This Joint
Filing Agreement may be executed in any number of counterparts, all of which
taken together shall constitute one and the same instrument.
Dated: As of April 14, 2004 *
--------------------------------------
Pasquale DeAngelis, individually, as a
member of ProQuest Associates II LLC,
as a member of ProQuest Associates II
LLC on behalf of ProQuest Investments
II, L.P. and ProQuest Investments II
Advisors Fund, L.P.
*
--------------------------------------
Jay Moorin, individually
*
--------------------------------------
Alain Schreiber, individually
*
--------------------------------------
Joyce Tsang, individually
*By: /s/ Pasquale DeAngelis
------------------------------------
Pasquale DeAngelis, Attorney-in-Fact
Power of attorney filed as an exhibit hereto
EX-24
3
ex99-2_990855.txt
EXHIBIT 24 - POWER OF ATTORNEY
Exhibit 24
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that each of the undersigned hereby
constitutes and appoints, as of the date hereof, Pasquale DeAngelis, his or her
true and lawful attorney-in-fact with full power of substitution, resubstitution
and revocation, for the undersigned and in the undersigned's name, place and
stead, in any and all capacities, including, but not limited to, the
undersigned's individual capacity and the undersigned's capacity as a member of
ProQuest Associates II LLC, a Delaware limited liability company ("Associates
II"), to execute all agreements, certificates, forms, instruments, or other
documents, and to take any action, necessary to file beneficial ownership
reports on Schedules 13D and 13G and Forms 3, 4 and 5 (including any amendments
thereto, and including any beneficial ownership reports which may in the future
be required by the Securities and Exchange Commission to be filed provided that
the purpose and form of such reports is substantially similar to Schedules 13D
or 13G or Form 3, 4 or 5) under the Securities Exchange Act of 1934 with the
Securities and Exchange Commission or any stock exchange or similar authority,
in connection with any equity investments in Pharmion Corporation by each of the
undersigned in his or her individual capacity and by each of ProQuest
Investments II, L.P. ("Investments II) and ProQuest Investments II Advisors
Fund, L.P. ("Advisors", and together with Associates II and Investments II, the
"Companies").
In connection with the appointment of such attorney-in-fact, each of the
undersigned hereby grants unto said attorney-in-fact full power and authority to
do and perform each and every act and thing which, in the opinion of such
attorney-in-fact, may be requisite, necessary, proper or of benefit to be done
in and about the premises, as fully to all intents and purposes as the
undersigned might or could do in person, thereby ratifying and confirming all
that said attorney-in-fact (or attorney-in-fact's substitute or substitutes),
may lawfully do or cause to be done by virtue hereof, it being understood that
the documents executed by such attorney-in-fact on behalf of the undersigned
pursuant to this Power of Attorney shall be in such form and shall contain such
terms and conditions as such attorney-in-fact may approve in his own discretion.
Each of the undersigned acknowledges that the foregoing attorney-in-fact, in
serving in such capacity at the request of the undersigned, is not assuming any
of the undersigned's or the Companies' responsibilities to comply with Section
13 or Section 16 of the Securities Exchange Act of 1934.
Dated: As of April 14, 2004 /s/ Jay Moorin
-----------------------------------
Jay Moorin
/s/ Alain Schreiber
-----------------------------------
Alain Schreiber
/s/ Joyce Tsang
-----------------------------------
Joyce Tsang